Leidos to support Naval Health Research Center with studies to improve health and readiness of U.S. service members
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Leidos (NYSE: LDOS) has been awarded a contract by the Naval Health Research Center (NHRC) to provide behavioral health research, operational assessments and data-driven analyses to support the psychological health and operational readiness of U.S. service members. The 66‑month contract has a total value of $56 million and focuses on identifying risk and protective factors across the deployment cycle, developing evidence-based strategies to enhance resilience, support informed decision-making and reduce adverse outcomes among military personnel.
Positive
- $56 million contract value over a 66-month period
- Long-term 66-month engagement supporting U.S. military health and readiness
- Expands Leidos’ behavioral health research work with the Naval Health Research Center
Negative
- None.
Details
News Market Reaction – LDOS
On Aug 25, the day this news came out, LDOS closed 2.83% below the previous close.
Data tracked by StockTitan Argus for the Aug 25 session.
Key Figures
- Contract Value
- $56 million
- NHRC contract total value
- Performance Period
- 66 months
- NHRC contract period of performance
- Experience
- more than 50 years
- Leidos research-support experience
- Navy Laboratories
- eight laboratories
- Navy Medical Research & Development Enterprise
Historical Context
-
Five-year Army cyber-defense follow-on contract was followed by a negative 24-hour reaction.
-
Quarterly results and raised full-year guidance were followed by a 10.01% gain.
-
Sierra Space selected Leidos payloads for 18 missile-warning satellites.
-
Naval intelligence infrastructure contract worth up to $64.8 million preceded a 2.7% gain.
-
Dividend declaration and authorization for up to 20 million repurchased shares preceded a 2.7% gain.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
behavioral health medical
epidemiology medical
disease surveillance medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
The work will focus on identifying risks and protective measures and interventions that affect the health, performance and readiness of military personnel throughout the deployment cycle, while developing evidence-based strategies that enhance resilience, support informed-decision making and reduce adverse outcomes. Leveraging more than 50 years of experience supporting research, Leidos will help NHRC translate scientific findings into practical solutions aimed at improving force readiness and optimizing performance and readiness within the military.
"This program reinforces the need for mission-critical health research in the military community," said Sarah McNichol, vice president of Behavioral Health & Readiness at Leidos Health. "It is vitally important we work to improve warfighter readiness by studying the various psychological factors that can impact military populations."
The NHRC is one of the eight laboratories within the Navy Medical Research & Development Enterprise tasked with optimizing the operational readiness and health of
About Leidos
Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Headquartered in Reston, Virginia, with approximately 50,000 global employees, Leidos reported annual revenues of approximately
Certain statements in this announcement constitute "forward-looking statements" within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management's current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the "Risk Factors" set forth in Leidos' Annual Report on Form 10-K for the fiscal year ended January 2, 2026, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.
Media contact:
Brandon Ver Velde
(571) 526-6257
brandon.p.vervelde@leidos.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/leidos-to-support-naval-health-research-center-with-studies-to-improve-health-and-readiness-of-us-service-members-302858587.html
SOURCE Leidos Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.